Literature DB >> 26205597

International Fetal Cardiac Intervention Registry: A Worldwide Collaborative Description and Preliminary Outcomes.

Anita J Moon-Grady1, Shaine A Morris2, Michael Belfort2, Ramen Chmait3, Joanna Dangel4, Roland Devlieger5, Stephen Emery6, Michele Frommelt7, Alberto Galindo8, Sarah Gelehrter9, Ulrich Gembruch10, Sofia Grinenco11, Mounira Habli12, Ulrike Herberg13, Edgar Jaeggi14, Mark Kilby15, Eftichia Kontopoulos16, Pablo Marantz11, Owen Miller17, Lucas Otaño11, Carlos Pedra18, Simone Pedra18, Jay Pruetz19, Ruben Quintero20, Greg Ryan21, Gurleen Sharland17, John Simpson17, Emanuel Vlastos22, Wayne Tworetzky23, Louise Wilkins-Haug24, Dick Oepkes25.   

Abstract

BACKGROUND: Invasive fetal cardiac intervention (FCI) has been reported in single-institution series, promoting technical and physiologic success.
OBJECTIVES: This study describes the creation of an international registry of cases presenting for FCI, intended to compile technical and outcome data from a multicenter cohort.
METHODS: For this initial analysis, the entire database of the International Fetal Cardiac Intervention Registry (IFCIR) was queried for details of diagnoses, procedures, and outcomes. Maternal-fetal dyads from January 2001 through June 2014 were included.
RESULTS: Eighteen institutions submitted data by data harvest. Of 370 cases entered, 245 underwent FCI: 100 aortic valvuloplasties from a previous single-center report (excluded from additional reporting here), an additional 86 aortic and 16 pulmonary valvuloplasties, 37 atrial septal cases, and 6 unclassified cases. FCI did not appear to affect overall survival to hospital discharge. Among live-born infants with a fetal diagnosis of aortic stenosis/evolving hypoplastic left heart syndrome, more than twice as many were discharged with biventricular circulation after successful FCI versus those meeting institutional criteria but without any or successful FCI (42.8% vs. 19.4%, respectively). When fetal deaths were counted as treatment failures, the percentages were similar: biventricular circulation at discharge was 31.3% versus 18.5% for those discharged with univentricular palliation. Survival to discharge for live-born fetuses with atrial restriction was similar to that of those undergoing technically successful versus unsuccessful FCI (63.6% vs. 46.7%, respectively), although criteria for diagnosis were nonuniform.
CONCLUSIONS: We describe the contents of the IFCIR and present post-natal data to suggest potential benefit to fetal therapy among pregnancies considered for possible intervention and support proposals for additional work.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  congenital heart defects; fetal cardiac intervention; fetal echocardiography; valvuloplasty

Mesh:

Year:  2015        PMID: 26205597     DOI: 10.1016/j.jacc.2015.05.037

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  25 in total

1.  Intrauterine Intervention of Pulmonary Atresia at 26th Gestational Week.

Authors:  Quan-Sheng Xing; Yue Sun; Gang Luo; Ai Zhang; Tao-Tao Chen; Si-Lin Pan
Journal:  Chin Med J (Engl)       Date:  2018-12-05       Impact factor: 2.628

Review 2.  Prenatal Counseling of Fetal Congenital Heart Disease.

Authors:  Caroline K Lee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

Review 3.  Fetal Treatment 2017: The Evolution of Fetal Therapy Centers - A Joint Opinion from the International Fetal Medicine and Surgical Society (IFMSS) and the North American Fetal Therapy Network (NAFTNet).

Authors:  Anita J Moon-Grady; Ahmet Baschat; Darrell Cass; Mahesh Choolani; Joshua A Copel; Timothy M Crombleholme; Jan Deprest; Stephen P Emery; Mark I Evans; Francois I Luks; Mary E Norton; Greg Ryan; Kuojen Tsao; Ross Welch; Michael Harrison
Journal:  Fetal Diagn Ther       Date:  2017-05-23       Impact factor: 2.587

4.  Congenital Heart Disease and Myelomeningocele in the Newborn: Prevalence and Mortality.

Authors:  J Kevin Wilkes; William E Whitehead; Yunfei Wang; Shaine A Morris
Journal:  Pediatr Cardiol       Date:  2021-03-10       Impact factor: 1.655

5.  Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome: A Decision Analysis.

Authors:  Sarah S Pickard; John B Wong; Emily M Bucholz; Jane W Newburger; Wayne Tworetzky; Terra Lafranchi; Carol B Benson; Louise E Wilkins-Haug; Diego Porras; Ryan Callahan; Kevin G Friedman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-04-07

6.  Care Levels for Fetal Therapy Centers.

Authors:  Ahmet A Baschat; Sean B Blackwell; Debnath Chatterjee; James J Cummings; Stephen P Emery; Shinjiro Hirose; Lisa M Hollier; Anthony Johnson; Sarah J Kilpatrick; Francois I Luks; M Kathryn Menard; Lawrence B McCullough; Julie S Moldenhauer; Anita J Moon-Grady; George B Mychaliska; Michael Narvey; Mary E Norton; Mark D Rollins; Eric D Skarsgard; KuoJen Tsao; Barbara B Warner; Abigail Wilpers; Greg Ryan
Journal:  Obstet Gynecol       Date:  2022-05-02       Impact factor: 7.623

Review 7.  Flow-Mediated Factors in the Pathogenesis of Hypoplastic Left Heart Syndrome.

Authors:  Anum Rahman; Rajiv R Chaturvedi; John G Sled
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-12

Review 8.  Whole Exome Sequencing: Applications in Prenatal Genetics.

Authors:  Angie C Jelin; Neeta Vora
Journal:  Obstet Gynecol Clin North Am       Date:  2018-03       Impact factor: 2.844

9.  Hypoplastic left heart syndrome: current modalities of treatment and outcomes.

Authors:  Smruti Ranjan Mohanty; Agastya Patel; Simran Kundan; Hari Bipin Radhakrishnan; Suresh Gururaja Rao
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-03-11

10.  Screening for congenital heart disease in a Singapore neonatal unit.

Authors:  Alvin Jia-Hao Ngeow; Mary Grace Tan; Jonathan Tze-Liang Choo; Teng-Hong Tan; Wei Ching Tan; Daisy Kwai-Lin Chan
Journal:  Singapore Med J       Date:  2019-12-10       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.